An implantable device containing insulin-producing cells to help treat Type 1 diabetes has moved closer to reality.
Underpinned by JDRF-funded research at the University of Arizona, the treatment is an implantable device that contains insulin-producing cells grown from stem cells.
The technology could one day offer a way for people with Type 1 diabetes go without insulin injections or infusions for months or years at a time. The science is challenging, requiring expertise in growing insulin-producing cells and creating special containers that protect the cells from the immune system.
Novo Nordisk and US start-up Procyon Technologies will now develop the treatment and speed up its path to clinical trials.
Find out more HERE.